What does CRPS treatment cost?
Published figures for complex regional pain syndrome range widely. A 2018 study of 35,316 insured United States patients found median total medical costs of $8,508 in the year of diagnosis and $43,026 over the eight years after. No published lifetime cost figure for the United States was found. Costs for stimulators and ketamine infusions are reported separately below.

What did the largest United States study of CRPS costs find?
The largest United States study of complex regional pain syndrome costs used insurance claims for 35,316 patients newly diagnosed between 2001 and 2012. Elsamadicy and colleagues, writing in Neuromodulation in 2018, reported a median total cost of $8,508 in the year of diagnosis, with a middle range of $3,943 to $16,666. The year before diagnosis already cost a median of $7,904.
Costs stayed elevated afterwards. Median yearly costs over the eight years after diagnosis ranged from $4,845 to $3,888. The study reported that "the median total cumulative cost 8-years after CRPS diagnosis was $43,026 and $12,037 for pain prescription costs." Total yearly cost was 2.17 times the patients' own cost before CRPS.
Which published cost figures for CRPS could be verified?
Six published sources give cost figures for CRPS care that could be traced to the study itself. The figures come from different countries, years and payers, so they cannot be added together.
| Figure | What was counted | Study |
|---|---|---|
| $8,508 median in the year of diagnosis; $43,026 median over eight years | Insurer-paid medical costs of 35,316 United States patients with CRPS | Elsamadicy et al., 2018 |
| $86,900 average insurance cost over five years | CRPS cases in Swiss accident insurance, 2008 to 2015 | Scholz-Odermatt et al., 2019 |
| $1,350 a year out of pocket | 50 Dutch patients with chronic CRPS, in 1990s-era dollars | Kemler and Furnee, Journal of Pain and Symptom Management, 2002 |
| $39,000 higher first-year cost with a spinal cord stimulator | 7,560 matched United States patients with chronic pain, including CRPS | Dhruva et al., 2023 |
| $60,000 less over a lifetime with a spinal cord stimulator | A cost model built on a Dutch trial of 54 patients with CRPS | Kemler and Furnee, Neurology, 2002 |
| $415 to $1,350 per ketamine infusion session | Average cost to the patient in the United States | Goordeen et al., ASRA Pain Medicine News, 2022 |
What does Medicare allow in California for nerve blocks and stimulator procedures?
Medicare's public payment file shows what was billed and what Medicare allowed in California in 2024 for nerve blocks and stimulator procedures. The figures cover every diagnosis, not CRPS alone. The file combines every Medicare Part B biller for a code, so an average is not the price of any one bill.
| Procedure (billing code) | Setting | Services | Average charge | Average allowed |
|---|---|---|---|---|
| Stellate ganglion block in the neck (64510) | Facility | 541 | $2,542 | $295 |
| Stellate ganglion block in the neck (64510) | Office | 136 | $721 | $117 |
| Sympathetic block in the middle or lower spine (64520) | Facility | 844 | $3,162 | $288 |
| Sympathetic block in the middle or lower spine (64520) | Office | 325 | $781 | $244 |
| Spinal cord stimulator lead placed through the skin (63650) | Facility | 11,249 | $11,827 | $2,792 |
| Spinal cord stimulator lead placed through the skin (63650) | Office | 908 | $5,722 | $1,725 |
| Spinal cord stimulator generator inserted or replaced (63685) | Facility | 3,644 | $25,538 | $12,367 |
Why is the billed charge so much higher than the amount Medicare allows?
The billed charge is the provider's list price, and the allowed amount is what Medicare's fee schedule recognises. In the 2024 California file, the average billed charge for a stellate ganglion block in a facility was $2,542 and the average Medicare allowed amount was $295. Other payers apply their own rules, so neither number predicts a particular bill.
What does a spinal cord stimulator cost over time?
Studies of spinal cord stimulator costs disagree, and the difference follows the method. A Dutch model published in Neurology in 2002 projected that a stimulator cost $4,000 more than control therapy in the first year and $60,000 less over a lifetime. A Canadian model in Pain Medicine in 2013 put the cost for CRPS at 11,216 Canadian dollars per quality-adjusted life year gained.
Real-world United States claims pointed the other way. Dhruva and colleagues reported in JAMA Neurology in 2023 that "total costs of care in the first year were $39 000 higher" with a stimulator and similar in the second year. In that study 22.1 percent of patients had a revision or removal within two years. The study covered several chronic pain conditions, not CRPS alone.
How often do spinal cord stimulators need further procedures?
Repeat procedures are a regular part of the cost of a spinal cord stimulator. A Dutch study by Geurts and colleagues in Neuromodulation in 2013 followed 84 patients with CRPS type I for up to 12 years. The study counted 122 further procedures in 51 patients, of which 44 were battery changes, 65 were related to equipment and 13 were due to complications. Sixty-one percent of patients had at least one further procedure.
What do ketamine infusions for CRPS cost?
A 2022 article in ASRA Pain Medicine News, published by the American Society of Regional Anesthesia and Pain Medicine, stated that "the average cost to the patient is anywhere between $415-$1,350 per infusion session." The same article stated that neither federal nor private insurers covered ketamine infusion therapy. That coverage statement dates from 2022, and coverage by individual plans since then was not checked.
CRPS protocols use repeated sessions. The 2009 outpatient trial by Schwartzman and colleagues gave four-hour infusions on 10 days. Ten sessions at the range quoted in the 2022 article would come to $4,150 to $13,500. That total is arithmetic on the published range, not a figure from a study.
What does CRPS cost a household beyond medical bills?
Published studies show lost income and unpaid help at home on top of medical bills. In a 2002 Dutch study of 50 patients with chronic CRPS and 43 spouses, household income fell by $4,000 when the patient was a man and $2,000 when the patient was a woman. Thirty-five of the 50 patients received a mean of 4.5 hours a week of domestic help.
In the Swiss accident insurance data, people with CRPS lost 330 days of work in the first two years after the accident, compared with 16.1 days for people without CRPS. The authors reported that "two-thirds of all CRPS cases developed long-term work incapacity of more than 90 days."
Is there a published lifetime cost for CRPS in the United States?
No. No published lifetime cost-of-illness figure for complex regional pain syndrome in the United States was found in the research reviewed for this site. The longest United States follow-up is the eight-year figure of $43,026 from the 2018 claims study. A lifetime figure quoted without a named study should be treated as unverified.
In an injury claim, future medical cost is projected person by person in a document called a life care plan, which prices each item of expected care. The life care plan guide explains how that projection is built.
Why can published averages understate a severe case of CRPS?
Published averages describe the typical patient with a CRPS diagnosis code. The $43,026 eight-year figure is a median, so half of the 35,316 patients cost more. The figure counts medical costs paid through insurance and leaves out lost wages, home help, travel and care that insurance refused.
The Swiss data show how far CRPS departs from an ordinary injury. Insurance costs for a CRPS case were 19 times the average for accidents without CRPS. The published medians do not describe a person with a spinal cord stimulator, repeated infusions or long-term work loss.
Common questions
Sources
Every source below was opened and read for this page. The date is when it was last checked.
- Prevalence and Cost Analysis of Complex Regional Pain Syndrome (CRPS): A Role for NeuromodulationStudy · Neuromodulation (Elsamadicy et al.), 2018 · checked
- Direct Health Care Cost and Work Incapacity Related to Complex Regional Pain Syndrome in Switzerland: A Retrospective Analysis from 2008 to 2015Study · Pain Medicine (Scholz-Odermatt et al.), 2019 · checked
- The impact of chronic pain on life in the householdStudy · Journal of Pain and Symptom Management (Kemler and Furnee), 2002 · checked
- Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophyStudy · Neurology (Kemler and Furnee), 2002 · checked
- Long-term Outcomes in Use of Opioids, Nonpharmacologic Pain Interventions, and Total Costs of Spinal Cord Stimulators Compared With Conventional Medical Therapy for Chronic PainStudy · JAMA Neurology (Dhruva et al.), 2023 · checked
- Cost-effectiveness of spinal cord stimulation therapy in management of chronic painStudy · Pain Medicine (Kumar and Rizvi), 2013 · checked
- Spinal cord stimulation for complex regional pain syndrome type I: a prospective cohort study with long-term follow-upStudy · Neuromodulation (Geurts et al.), 2013 · checked
- Ketamine Infusion Therapy and Its Role in Chronic PainOrganization · ASRA Pain Medicine News (Goordeen et al.), 2022 · checked
- Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled studyStudy · Pain (Schwartzman et al.), 2009 · checked
- Medicare Physician and Other Practitioners, by Geography and Service (2024 service year)Dataset · Centers for Medicare and Medicaid Services, 2024 · checked
- Judicial Council of California Civil Jury Instructions (CACI), 2026 edition: Nos. 3903A, 3904A, 3905A and 3932Jury instruction · Judicial Council of California, 2026 · checked
- Outcome of the complex regional pain syndromeStudy · The Clinical Journal of Pain (de Mos et al.), 2009 · checked

CRPS treatment
Life care plans for CRPS